Fangyuan Health (06086) announced the distribution results, selling 23.8 million shares globally, with 30% sold publicly in Hong Kong and 70% sold internationally. The final offering price was HKD 8.18 per share, with a net raise of approximately HKD 670.9 million from the global sale. Trading of the expected shares in lots of 500 will start on the Hong Kong Stock Exchange on Tuesday, July 9, 2024 at 9:00 AM.
Among them, the public offering in Hong Kong was oversubscribed by 16.63 times, while the international offering was oversubscribed by 1.66 times.